Honeywell vs 3M: Which Is the Better Buy in 2026?

Both are diversified industrial conglomerates, but 3M's legal situation is the defining fact of its current investment case. PFAS chemical contamination and Combat Arms earplug lawsuits have required billions in settlements and continue to create balance sheet uncertainty. Honeywell faces no equivalent liability overhang and has used its clean balance sheet to invest in automation technology, building efficiency systems, and aerospace components. The business quality is comparable in many ways; the legal liability profile is not.

Honeywell's portfolio management has been cleaner — it has divested underperforming businesses and invested in higher-margin automation, aerospace, and building technologies without accumulating the legal liabilities that have defined 3M's last decade. 3M's PFAS chemical litigation and earplug lawsuit settlements have cost billions and created ongoing overhang that management cannot fully control or predict. Honeywell's operational focus allows investors to evaluate the business on its actual industrial performance. Until 3M's liability tail is fully resolved, that discount exists for a reason.